SCHEMBL5216645

SCHEMBL5216645

CC/C=C\C(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL400439 1.00
SCHEMBL29098358 1.00 TRPA1 (0.35)
SCHEMBL944423 1.00 TRPA1 (0.35)
SCHEMBL30619209 1.00 TRPA1 (0.35)
SCHEMBL254292 1.00
SCHEMBL29100294 0.86 PAOX (0.41)
SCHEMBL29100311 0.86 PAOX (0.41)
SCHEMBL29100318 0.86 PAOX (0.41)
SCHEMBL29100289 0.86 PAOX (0.41)
SCHEMBL3959907 0.85 PPARA (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113025679-B Enzymatic preparation process of cefcapene precursor acid of t-butyloxycarbonyl 石药集团内蒙古中诺药业有限公司 2023-04-28 CN disclosed
EP-3233881-B1 UNIVERSAL METHYLATION PROFILING METHODS UNIV COLUMBIA (US) 2020-02-12 EP disclosed
WO-2019051184-A1 AMIDE AND NITRILE COMPOUNDS AND METHODS OF PRODUCING AND USING THEREOF NOVOMER, INC. (US) 2019-03-14 WO disclosed
US-20160355542-A1 UNIVERSAL METHYLATION PROFILING METHODS THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2016-12-08 US disclosed
WO-2015077370-A1 ANTI-CANCER AGENTS AND PREPARATION THEREOF PURDUE RESEARCH FOUNDATION (US) 2015-05-28 WO disclosed
WO-2014204861-A1 UNIVERSAL METHYLATION PROFILING METHODS THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2014-12-24 WO disclosed
US-20070066664-A1 HIV PROTEASE INHIBITORS, COMPOSITIONS CONTAINING THE SAME, THEIR PHARMACEUTICAL USES, MATERIALS FOR THEIR SYNTHESIS PFIZER INC 2007-03-22 US disclosed
US-7169932-B2 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses, material for their synthesis PFIZER INC. (US) 2007-01-30 US disclosed
EP-1739082-A1 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis Agouron Pharmaceuticals , Inc. (US) 2007-01-03 EP disclosed
US-20050250707-A1 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis CANAN KOCH STACIE S 2005-11-10 US disclosed
US-6953858-B2 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis AGOURON PHARMACEUTICALS, INC. (US) 2005-10-11 US disclosed
US-20040171842-A1 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses, material for their synthesis PFIZER INC 2004-09-02 US disclosed
US-20030153507-A1 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis AGOURON PHARMACEUTICALS, INC. 2003-08-14 US disclosed